Testing for chronic kidney disease: a position statement from the National Kidney Foundation.

Chronic kidney disease (CKD) is common in the United States. The estimated prevalence of CKD in US adults was 11.7% +/- 0.8% in 2000, based on the National Health and Nutrition Examination Survey (NHANES). Global estimates for CKD prevalence are less certain, but recent studies in Europe, Australia, and China suggest a high prevalence. The most common risk factors for CKD include diabetes, hypertension, cardiovascular disease, a family history of CKD, and age greater than 60 years. Major outcomes of CKD include progression to kidney failure, development of complications of impaired kidney function, and increased risk for cardiovascular disease. CKD is usually silent until its late stages, thus many patients with CKD are detected only shortly before the onset of symptomatic kidney failure, when there are few opportunities to prevent adverse outcomes. Earlier detection allows for more time for evaluation and treatment but requires explicit testing strategies for asymptomatic individuals at increased risk. In the majority of patients, CKD can be detected with 2 simple tests: a urine test for the detection of proteinuria and a blood test to estimate the glomerular filtration rate (GFR). These 2 tests facilitate detection of CKD by all physicians by allowing for identification of CKD without first requiring determination of its cause. Understanding the strengths and limitations of CKD testing is critical for appropriate implementation of these recommendations. Application of CKD testing in national and international screening and surveillance programs could improve public health related to CKD.

[1]  Neil R. Powe,et al.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. , 2007, Kidney international.

[2]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[3]  A. Levey,et al.  CKD: common, harmful, and treatable--World Kidney Day 2007. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  S. Ito,et al.  Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease , 2007, Clinical and Experimental Nephrology.

[5]  T. Hostetter,et al.  Automatic reporting of estimated glomerular filtration rate--just what the doctor ordered. , 2006, Clinical chemistry.

[6]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[7]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[8]  N. Powe,et al.  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. , 2006, Journal of the American Society of Nephrology : JASN.

[9]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[10]  Michael M Engelgau,et al.  Chronic Kidney Disease: A Public Health Problem That Needs a Public Health Action Plan , 2006, Preventing chronic disease.

[11]  Sudhir V. Shah,et al.  SPECIAL ANNOUNCEMENT: World Kidney Day: An idea whose time has come , 2006 .

[12]  Sudhir V. Shah,et al.  World Kidney Day: an idea whose time has come. , 2006, Nephrology.

[13]  Sudhir V. Shah,et al.  World Kidney Day: an idea whose time has come. , 2006, The National medical journal of India.

[14]  W Greg Miller,et al.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. , 2006, Clinical chemistry.

[15]  A. Collins,et al.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015. , 2005, Journal of the American Society of Nephrology : JASN.

[16]  K. Reynolds,et al.  Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. , 2005, Kidney international.

[17]  Katrin Uhlig,et al.  Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[19]  J. Koopmeiners,et al.  An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. , 2005, Journal of the American Society of Nephrology : JASN.

[20]  T. Greene,et al.  Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[21]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[22]  T. Hostetter,et al.  Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  T. Larson,et al.  Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.

[24]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[25]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[26]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.

[27]  N. Powe,et al.  Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.

[28]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[29]  R. Nelson,et al.  Testing for microalbuminuria in 2002: barriers to implementing current guidelines. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  David W Dunstan,et al.  Prevalence of kidney damage in Australian adults: The AusDiab kidney study. , 2003, Journal of the American Society of Nephrology : JASN.

[31]  S. Yusuf,et al.  Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. , 2003, Journal of the American Society of Nephrology : JASN.

[32]  Nancy Fink,et al.  The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.

[33]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  G. Wolf,et al.  Leptin and renal disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  F Vinicor,et al.  The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.

[37]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[38]  A. Kausz,et al.  Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. , 1999, Journal of the American Society of Nephrology : JASN.

[39]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[40]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  E. Rubinstein,et al.  Prediction of creatinine clearance from serum creatinine concentration based on lean body mass , 1981, Clinical pharmacology and therapeutics.

[42]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .